関連する実験動画

Updated: Feb 17, 2026

Real Time Measurements of Membrane Protein:Receptor Interactions Using Surface Plasmon Resonance SPR
09:35

Real Time Measurements of Membrane Protein:Receptor Interactions Using Surface Plasmon Resonance SPR

Published on: November 29, 2014

23.6K

新しい定量受容体機能モデルであるSABREの能力は,単一の統一されたフィットで,困難な濃度効果データからさえも受容体結合を定量化します

Barbara Olah1,2, Vera Tarjanyi3, Gabor Viczjan3

  • 1Department of Orthodontics, Faculty of Dentistry, University of Debrecen, Debrecen, Hungary.

Frontiers in pharmacology
|February 16, 2026
PubMed
まとめ

シグナル増幅,結合親和,受容体活性化効率 (SABRE) モデルは,多線型モデルに拡張されました. この新しいモデルは,単一のグローバルフィットを使用して,不確実性がある場合でも,機能データを信頼性のある方法で分析します.

キーワード:
Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd Kd っていうのは,大喜んでいるからやってくれることになったSABREモデルのモデルです.アトリウム アトリウムカーブフィッティングは,カーブフィッティングに適合する.機能データ 機能データイノトロピストロピーとは受容体の親和感感受容体の親和感がある.

さらに関連する動画

Determining Binding Affinity KD of Radiolabeled Antibodies to Immobilized Antigens07:39

Determining Binding Affinity KD of Radiolabeled Antibodies to Immobilized Antigens

Published on: June 23, 2022

7.2K
High-resolution Spatiotemporal Analysis of Receptor Dynamics by Single-molecule Fluorescence Microscopy15:13

High-resolution Spatiotemporal Analysis of Receptor Dynamics by Single-molecule Fluorescence Microscopy

Published on: July 25, 2014

11.9K

関連する概念動画

Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.8K
The Two-State Receptor Model01:29

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
3.1K
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
15.3K
Physiological Pharmacokinetic Models: Assumption with Protein Binding01:13

Physiological Pharmacokinetic Models: Assumption with Protein Binding

Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
280
Pharmacodynamic Models: Emax Drug–Concentration Effect Model01:18

Pharmacodynamic Models: Emax Drug–Concentration Effect Model

The Emax drug-concentration effect model is central to pharmacodynamics in drug discovery and development. This model is predicated on the receptor occupancy theory, which posits that the effect of a drug is directly related to the number of receptors occupied by the drug and the resultant complex formation.The model describes the reversible interaction between a drug (C) and a receptor (R) to form a drug-receptor complex (RC). The kinetics of this interaction are quantified by an equation that...
34
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.7K